Deutsche Bank upgrades Gilead on its HIV treatment franchise
Go back to Deutsche Bank upgrades Gilead on its HIV treatment franchise| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.68 -3.18 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.86 | 52 Week High | $108.63 | |||
| Open | $149.47 | 52 Week Low | $71.39 | |||
| Day High | $149.47 | P/E | 80.49 | |||
| Day Low | $144.88 | EPS | $1.81 | |||
| Volume | 3,946,913 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1174.61 -1.49 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1176.10 | 52 Week High | $88.16 | |||
| Open | $1172.66 | 52 Week Low | $67.88 | |||
| Day High | $1180.00 | P/E | 271.90 | |||
| Day Low | $1162.93 | EPS | $4.32 | |||
| Volume | 2,451,825 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 541.69 -5.86 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $547.55 | 52 Week High | $134.71 | |||
| Open | $547.09 | 52 Week Low | $73.31 | |||
| Day High | $549.57 | P/E | N/A | |||
| Day Low | $540.08 | EPS | $-1.98 | |||
| Volume | 886,913 | |||||
